Key facts
- This page summarizes Reshma P. Shetty's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Feb 2023, 16:35.
Reshma P. Shetty - 31 Jan 2023 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)
- Reporting relationship
- President, COO & Founder, Director, 10%+ Owner
- Issuer ticker
- DNA
- Reported as of
- 31 Jan 2023
- Net transaction value
- -$1,217,769
- SEC form
- 4
- Accepted by SEC
- 02 Feb 2023, 16:35:23 UTC
- Prior SEC filing
- 31 Jan 2023
- Next SEC filing
- 03 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen Tepichin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Reshma P. Shetty filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 02 Feb 2023.
Change
- Previous filing in this sequence was filed on 31 Jan 2023.
- Current net transaction value: -$1,217,769.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- $276,376
- Shares
- -149,554
- Change %
- -0.99%
- Price
- $1.85
- Shares after
- 14,893,820
- Date
- 31 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- $276,376
- Shares
- -149,554
- Change %
- -0.99%
- Price
- $1.85
- Shares after
- 14,893,808
- Date
- 31 Jan 2023
- Ownership
- By Spouse
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- $72,642
- Shares
- -37,650
- Change %
- -0.25%
- Price
- $1.93
- Shares after
- 14,856,170
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F2, F3
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- $296,188
- Shares
- -154,910
- Change %
- -1%
- Price
- $1.91
- Shares after
- 14,701,260
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
DNA
transaction
Class A Common Stock
Sale
- Transaction value
- $296,188
- Shares
- -154,910
- Change %
- -1%
- Price
- $1.91
- Shares after
- 14,738,898
- Date
- 01 Feb 2023
- Ownership
- By Spouse
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
Footnote F2
The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
SEC remarks
President, COO & Founder